My Research – Session 4: Risk Predictions – Statistical versus Machine learning methods

Session 4 (Wednesday 12th May at 19:00 GMT) –  CLICK HERE to REGISTER

 

We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by: Pinkie Chambers and Bruce Burnett

 

Biography (Pinkie Chambers) – Pinkie is a clinical academic at University College London (UCL) and University College NHS Foundation Trust.   Her research activities are all around improving the delivery of systemic anticancer treatments and has experience of using large datasets and prognostic modelling techniques. She has held various roles within cancer including developing new clinic pharmacy services at UCLH and Lead Pharmacist for London Cancer. She the current co-chair of the UK Chemotherapy board , joint audit, and research lead for BOPA and chair of The Chemotherapy Expert Reference group at the NCL cancer alliance as well as a member of the Heath Foundation Q Community.

 

 

 

 

 

Biography (Bruce Burnett) – My name is Bruce Burnett and I am a final year PhD student at Swansea University. I have a Master of Medical Sciences in Clinical Oncology and a Batchelor of Science degree in Pharmacy with a postgraduate certificate in Supplementary Prescribing.  My current research relates to the prediction of colorectal cancer from routinely collected health and social data using machine learning techniques. Previously I was an oncology pharmacist with over 15 years experience and an interest in head and neck and upper GI cancers. I am also a guest lecturer at Coventry University on the topic of biopharmaceuticals in the management of cancer.

 

 

 

 

 

 

 

 

 

Please Note:

-Webinars will start at 19:00 BST and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email [email protected])

-Webinars are FREE to access for BOPA Paid Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK

-Webinars will aim to be on a monthly basis

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

 

Latest News

By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article
By Suriya Marshall on 27th September 2026

Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation”

Session Title: Cancer Vaccines: “Transforming Vaccine Delivery Through Innovation” When: 12th October 2026. From 1-2pm Online event  Session Outline: This presentation explores the role of cancer vaccines in transforming cancer…

Read article
By BOPA on 8th September 2026

Register now: Immunotherapy: Beyond Checkpoint Inhibitors

Immunotherapy: Beyond Checkpoint Inhibitors WHEN: Tuesday 17th November 2026 WHERE:  Wellcome Collection, 183 Euston Road, London, NW1 BE COST: A non-refundable payment of £25.00. We are pleased to announce registration is now available for…

Read article
By BOPA Executive Committee on 7th September 2026

Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway

We are delighted to see the Royal College of Pharmacy launch its new Enhanced Curriculum and Credentialing Pathway today. This curriculum is the product of a truly collaborative effort across…

Read article